Navigation Links
Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL)
Date:12/8/2008

13; E: hth@genmab.com

Cautionary statement regarding forward-looking statements for GSK

Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK' s operations are described under 'Risk Factors' in the 'Business Review' in the company's Annual Report on Form 20-F for 2007.

Registered in England & Wales:

No. 3888792

Registered Office:

980 Great West Road

Brentford, Middlesex

TW8 9GS

Forward looking statement for Genmab

This press release contains forward looking statements. The words "believe", "expect", "anticipate", "intend" and "plan" and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with product discovery and development, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products obsole
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
4. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
5. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
10. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
11. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014  RESMED INC. (NYSE: RMD ) ... fiscal year 2015 results on Thursday, January 22, 2015, after ... with ResMed,s results will be issued after 1:00 p.m. US ... discuss operating results and future outlook. The earnings ... Time and the live webcast of the call can be ...
(Date:12/19/2014)... CITY, Kan. , Dec. 18, 2014 /PRNewswire/ ... PETX ), a biopharmaceutical company focused on the ... companion animals, today announced positive results from its ... innovative drug for treating pain in dogs with ... improvements in pain assessment scores that were statistically ...
(Date:12/17/2014)... and SAN DIEGO , Dec. ... PHG ; AEX: PHIA) and Volcano Corporation (NASDAQ: ... measurement solutions for cardiovascular applications, today announced that they have ... Philips will commence a tender offer to acquire all of ... per share, or a total equity purchase price of USD ...
Breaking Medicine Technology:ResMed To Announce Second Quarter 2015 Results 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8
... STEWARTVILLE, Minn., July 19, 2011 Rochester Medical Corporation (NASDAQ: ... markets close on Thursday, July 28, 2011.  The Company will ... report.  The call will begin at 3:30 p.m. central time ... webcast by Thomson Reuters and can be accessed at Rochester ...
... Ontario, July 19, 2011 Valeant Pharmaceuticals International, Inc. ... today that its subsidiary, Valeant International (Barbados) SRL ("VIB"), ... ("sanofi-aventis") for the Canadian marketing and distribution rights to ... to be used in conjunction with oral COX-2 inhibitors ...
Cached Medicine Technology:Valeant Pharmaceuticals Announces Distribution Agreement for Zuacta™ in Canada 2
(Date:12/19/2014)... Dennis Thompson HealthDay Reporter ... entrance into the United States -- along with Angelina ... -- have highlighted cracks in the nation,s public health ... policy report released Thursday. Half of U.S. states ... infectious disease outbreaks. That was the main conclusion of ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 Novellus ... Patient Care: Pharmacy & Clinics™, an independent journal ... team treating and caring for patients inside the ... care expands to provide optimal access to quality ... a forum for the team treating and coordinating ...
(Date:12/19/2014)... From November 24, 2014, Siddhi Yoga ... year 2014 in its Goa retreat . This is ... Indian winters, from November to March, Siddhi Yoga will organize ... Arambol, Goa. The Goa training sessions will conclude in March ... teacher training, the 10th intake is also a 200 ...
(Date:12/19/2014)... December 19, 2014 Consilium Staffing, ... the AMSUS Society for Federal Health Professionals annual ... tenens industry to military and federal healthcare providers. ... National Veterans Small Business Engagement (NVSBE) conference last ... to be a vital solution in addressing our ...
(Date:12/19/2014)... News) -- The tragic death from "rat-bite fever" of a ... pet rodents, according to a report from the U.S. Centers ... rare but potentially fatal illness that should be considered in ... history of rodent exposure is reported," said a team led ... The case outlined in the report occurred in August ...
Breaking Medicine News(10 mins):Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 3Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 4Health News:The Transformation of Retail Pharmacies into a Healthcare Delivery Center 2Health News:The Transformation of Retail Pharmacies into a Healthcare Delivery Center 3Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 2Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 3Health News:Consilium Staffing Increasing Awareness of Locum Tenens through Conference Appearances 2Health News:Scratch From Pet Rat Kills Child; CDC Warns of Risk 2
... Public Can Directly Interact with Harvard Medical Doctors Via ... First Live Chat with Dr. Julie Silver, Harvard Medical ... 8 p.m. EDT, BOSTON, Oct. 28 Beginning ... top Harvard Medical doctor -without,leaving your laptop. Gather ...
... As October, Breast Cancer Awareness,Month, draws to ... Georgia (BCBSGa),understands that it is truly a year-round ... breast cancer care and awareness for its members.,The ... with breast,cancer and their physicians, has helped more ...
... on the Proposed Transfer of Listing of its ... H Shares from GEM to ... Shandong Luoxin Pharmacy,Stock Co., Ltd. (HKEx: 8058), announced its third ... a strong growth in turnover,and profit attributable to shareholders., ...
... Patients Lose 35% More Weight and Have Better Quality ... Surgery Itself, GAINESVILLE, Fla., Oct. 28 Those ... surgery lost 35,percent more weight the first year and ... according to new patient and bariatric surgeon surveys,conducted by ...
... health costs and medical crises fuel many foreclosures, bankruptcies ... and Deborah Krinsky of Magalia, Calif., have seen their ... And their health-care costs have put them in a ... and potential heart problems, Deborah,s connective tissue disorder and ...
... MPX Workstation and International Business Drive Top-Line Growth; ... Quarter of Profitability, WESTFORD, Mass., Oct. 28 ... manufacturer of a broad array of,light-based aesthetic treatment systems, ... ended September 30, 2008., Third-Quarter 2008 Financial Results, ...
Cached Medicine News:Health News:Gather and Harvard Health Publications Launch New Programs to Bring Harvard Medical School Doctors' Expertise Online 2Health News:Blue Cross and Blue Shield of Georgia Expands Breast Cancer Care Program 2Health News:Blue Cross and Blue Shield of Georgia Expands Breast Cancer Care Program 3Health News:Luoxin Announces 2008 Third Quarterly Results; Profit Attributable to Shareholders Surged 62.9% to Approximately RMB 138,141,000 2Health News:New National Patient and Surgeon Surveys Show Post-Surgical Care Critical to Optimal Weight Loss After Bariatric Surgery 2Health News:New National Patient and Surgeon Surveys Show Post-Surgical Care Critical to Optimal Weight Loss After Bariatric Surgery 3Health News:New National Patient and Surgeon Surveys Show Post-Surgical Care Critical to Optimal Weight Loss After Bariatric Surgery 4Health News:New National Patient and Surgeon Surveys Show Post-Surgical Care Critical to Optimal Weight Loss After Bariatric Surgery 5Health News:Medical Debt Sending Many Over Financial Brink 2Health News:Medical Debt Sending Many Over Financial Brink 3Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 2Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 3Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 4Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 5Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 6Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 7Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 8Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 9Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 10Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 11
Exactech's AcuMatch C-Series (cemented femoral stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
The cemented hip joint prosthesis system....
The uncemented hip joint prosthesis system....
The cemented hip joint prosthesis system....
Medicine Products: